Related Experiment Videos

Acrodermatitis enteropathica: recent findings concerning clinical features, pathogenesis, diagnosis and therapy

Insights

Acrodermatitis enteropathica (AE), a genetic zinc deficiency disorder, was diagnosed in two siblings. Zinc sulfate (ZnSO4) treatment normalized zinc levels and improved clinical symptoms, confirming AE

Area of Science:

  • Genetics
  • Pediatrics
  • Dermatology

Background:

  • Acrodermatitis enteropathica (AE) is a rare genetic disorder characterized by zinc malabsorption.
  • Clinical manifestations include skin lesions, gastrointestinal issues, and immune dysfunction.
  • Early diagnosis and treatment are crucial for managing AE.

Purpose of the Study:

  • To report a case of acrodermatitis enteropathica (AE) in two siblings.
  • To investigate the clinical and biochemical features of AE.
  • To evaluate the efficacy of zinc sulfate (ZnSO4) treatment.

Main Methods:

  • Clinical assessment of two siblings diagnosed with AE.
  • Serum zinc and fatty acid levels were measured.
  • Jejunal biopsies were examined histologically and ultrastructurally.

Main Results:

  • Both siblings presented with characteristic AE symptoms and significantly low serum zinc levels.
  • One patient showed altered serum fatty acid levels during exacerbation.
  • Zinc sulfate (ZnSO4) supplementation led to clinical improvement and normalized serum zinc levels.
  • Histological examination revealed non-specific enterocyte changes and Paneth cell abnormalities.

Conclusions:

  • This case study highlights the importance of recognizing AE symptoms in pediatric patients.
  • Serum zinc levels are a key diagnostic marker for AE.
  • Zinc supplementation is an effective treatment for acrodermatitis enteropathica (AE).

Related Concept Videos